Manufacturing Industry

LILLY (ELI) & COMPANY - Cialis for Once-a-Day.

PR Newswire UK Disclose, June, 2007

 
Date: June 25, 2007 
 
For Release: Immediately 
 
Refer to: Keri McGrath, Lilly, (317) 651-6001 
 
Frances Beves, Lilly,  44 127 648 4810 
 
 CialisA[R] (tadalafil) for Once-a-Day Use Approved for the Treatment of Erectile 
                      Dysfunction by European Commission 
 
Daily dosing option is first prescription oral treatment to offer uninterrupted 
               management of erectile dysfunction in select men 
 
INDIANAPOLIS, Ind. -- Lilly (NYSE: LLY) announced today that the European 
Commission has granted marketing authorization for Cialisacents (tadalafil) 2.5 mg 
and 5 mg, an oral PDE5 inhibitor dosed once daily to treat erectile dysfunction 
(ED). The approval decision follows a positive opinion adopted April 26, 2007, 
by the Committee for Medicinal...

            
        
    
    	    
                
                
	
Premium Content Partnership | HighBeam Research provides an in-depth online archive library of reference works. HighBeam Research

 

BNET TalkbackShare your ideas and expertise on this topic

Please add your comment:

  1. You are currently: a Guest |
  2.  

Basic HTML tags that work in comments are: bold (<b></b>), italic (<i></i>), underline (<u></u>), and hyperlink (<a href></a)

advertisement
advertisement
  • Click Here
  • Click Here
  • Click Here
advertisement